GPR52, a brain-specific G protein-coupled receptor co-localized with D1 and D2 dopamine receptors in key schizophreniarelevant regions, such as medial prefrontal cortex and striatum, represents a promising therapeutic target for...
Chen et al. (Thu,) studied this question.